Whatsapp
Facebook
Twitter
Instagram

MS (Multiple Sclerosis)

MS

MS (Multiple Sclerosis) Therapy in Turkey with Stem Cells

The advancement of the disease in MS (Multiple Sclerosis) patients is substantially slowed by Stem Cell Therapy, and the patient's current state is greatly improved. Stem cell therapy protects the brain from autoimmune inflammation and heals damaged brain and spine cells. Patients who receive this medication at the start of the condition can return to work.

●    With stem cell therapy, the plaques that develop in MS begin to dissolve, as shown by MR imaging. Stem cell therapy, on the other hand, delays the course of the disease by strengthening the body's defensive system.

●    As a result of the therapy, improvements such as stabilization of the patient's condition, slowing the progression of the disease, shortening the duration of the periods when the disease is aggravated, improvement in the patient's psychology, emotions, and comprehension, strengthening of immunity, and increased quality of life have been observed.

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹The amount of cells to be supplied is decided by the patient's age and weight. The therapy is delivered in three 45-day periods or three consecutive days.

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹The given stem cells are tiny enough to pass through brain cells. As a result, early diagnosis enhances the therapy's success percentage dramatically.

What is MS?

Multiple sclerosis is a chronic neurological illness that affects the brain, spinal cord, and optic nerves. It is most frequent in individuals aged 20 to 40, although it can also affect children and the elderly. It is the second leading cause of neurological impairment in adolescents. It often starts with recurring assaults. These bouts often last a few weeks and can resolve partially or entirely spontaneously or with pharmacological therapy. In certain situations, assaults may not resolve completely, resulting in long-term neurological effects. Neurological results in certain circumstances may suggest a sluggish progressive trend.

What are the symptoms of MS?

MS symptoms vary according to the kind of illness and the individual. They may also differ based on the nerves involved and the amount of the injury. People with MS may experience any of the disease's symptoms, either as attacks and improvements or as a progressively increasing course.

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Numbness, tingling, pins and needles, electrification

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Dizziness

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Loss of strength, spasm, muscle stiffness, cramps, pain

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Vision loss, double vision

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Excretory function problems

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Speech disorder

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Sexual dysfunction

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Loss of balance, inability to walk properly

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Nausea

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Fatigue

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹Memory loss, depression, cognitive difficulties

●    β€‹β€‹β€‹β€‹β€‹β€‹β€‹β€‹β€‹β€‹β€‹β€‹β€‹β€‹Dysphagia

Causes of MS

Whilst it is unknown what causes multiple sclerosis, it is believed to be an autoimmune illness in which the body's immune system assaults its own tissues. This process causes myelin destruction in MS, which is a material that protects and coats the nerve wires in the brain and spinal cord. When myelin is destroyed, signals traveling through the nerves might become sluggish or stopped.

Although it is unclear why some people get multiple sclerosis and others do not, it is assumed that a variety of variables, ranging from hereditary factors to childhood illnesses, have a role.

Therapy of MS

Although there is no cure for multiple sclerosis, it is feasible to eradicate the neurological symptoms associated with an attack, as well as avoid attacks and persistent neurological abnormalities.

The major medication utilized in the eradication of neurological signs associated with the attacks is steroid (cortisone) therapy. Although it may be provided via a variety of methods, the most frequent method is intravenous high-dose sequential or intermittent delivery. This therapy frequently results in total or almost complete healing.

If the attack findings do not improve despite steroid therapy, plasmapheresis (the elimination of specific antibodies in the blood from the circulation by plasma filtration) is an option. This therapy removes the antibodies that cause the sickness from the body, allowing the patient to recover.

Preventive therapy is now one of the most beneficial aspects of MS therapy. The goal is to prevent neurological impairment from developing before it settles and accumulates. episodes are totally avoided in 30-40% of patients, while the frequency and severity of episodes are reduced in the remaining 30%.

Therapy of MS with Stem Cells

It is not feasible to claim that stem cell therapy cures the condition fully. However, the plaques that develop in MS begin to dissolve with therapy, as shown by MR scans. When the plaques vanish, the patient's problems begin to fade and regress.

Stem cell therapy reduces autoimmune inflammation in the brain and restores damaged brain and spine cells in MS patients. Stabilization of the patient's condition, decrease in disease progression, shortening the duration of aggravated periods, decreased spasticity (muscles being severely contracted) of hands and feet, development in walking, improvement in coordination and balance, progress in speech, improvement in the patient's psychology, emotions, and comprehension, strengthening of immunity, and improvement of internal organ.

Patients who receive this medication at the start of the condition can return to work.

Stem cell therapy, on the other hand, delays the course of the disease by strengthening the body's defensive system. If plaque development recurs in the long run, the stem cell technique may need to be used again.

Method of administration:

The amount of cells to be supplied is decided by the patient's age and weight. Mesenchymal stem cells (produced from the patient's own adipose tissue or bone marrow) or fetal stem cells are used in therapy. The therapy of the patient is determined by the patient's condition. It can be done in three 45-day increments or three consecutive days. The therapy regimen is carefully changed based on the patient's condition, and each patient may receive a different procedure.

Success Rates in Therapy 

The given stem cells are tiny enough to pass through brain cells. As a result, early diagnosis enhances the therapy's success percentage dramatically. Previous research found that stem cell therapy had a high percentage of good outcomes. In 83% of patients, this therapy greatly slowed disease development and helped to alleviate the current critical illness.

FREQUENTLY ASKED QUESTIONS

Are there different types of MS?

There are four types of MS:

Clinical Isolated Syndrome (CIS):

It is the initial episode of MS in which recognizable signs of the illness are observed and symptoms endure at least 24 hours. Patients at this stage do not yet match the MS diagnostic criteria since some CIS patients do not develop MS.

Relapsing-Remitting MS (RRMS):

It is the most common condition that affects 85 percent of people with MS and includes new or increased symptoms.

Primary Progressive MS (PPMS):

Since the commencement of symptoms, the patient's neurological functions have steadily deteriorated (accumulation of impairment), with no early relapses or remissions. PPMS accounts for around 15% of all cases.

Secondary Progressive MS (SPMS):

It is a condition where the disease progresses continuously after the first attacks or after relapse and remission.

Who is most likely to have MS?

First and foremost, Multiple Sclerosis (MS) is not a deadly illness. There have been several research conducted on this issue. In these investigations, no significant difference in mean life expectancy was reported between MS and healthy persons. MS is not a communicable illness.

This condition is considered to be influenced by age, gender, family history, certain infections, ethnicity, and geography, as well as several other autoimmune system disorders. The condition is more common among young individuals aged 20 to 40, women, cultures with a high socioeconomic level, and those with a high education level who live in cities.

How is MS diagnosed?

There is no single device for diagnosing MS. Generally, the diagnosis is made according to the patient's neurological history, neurological examination findings, cranial and spinal MRI findings, in some cases cerebrospinal fluid findings and in some cases by electrophysiological tests. Rarely, a biopsy may be necessary to clarify other diagnostic possibilities.

More Info

All Rights Reserved. © 2023 Outbox Ajans

The #1 medical tourism platform